Screener
Twist Bioscience Corporation TWST Reportable Segment — Cost of revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept twst:CostOfRevenueExcludingDepreciationAmortizationAndShareBasedCompensationExpense.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (in thousands) | Three months ended March 31, 2026 | Three months ended March 31, 2025 | Six months ended March 31, 2026 | Six months ended March 31, 2025 |
|---|---|---|---|---|
| Revenues | $110,715 | $92,793 | $214,413 | $181,506 |
| Costs and expenses: | ||||
| Cost of revenues[1] | $47,402 | $40,373 | $91,408 | $80,744 |
| Research and development expenses[1] | 17,366 | 19,952 | 32,712 | 38,078 |
| Selling, general and administrative expenses[1] | 59,255 | 47,298 | 117,034 | 93,786 |
| Litigation settlement costs, net of recoveries | 7,205 | — | 7,205 | — |
| Depreciation and amortization | 6,414 | 6,402 | 12,608 | 12,784 |
| Stock-based compensation expense | 18,936 | 20,328 | 32,209 | 32,319 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's reportable segment — cost of revenues?
- Twist Bioscience Corporation (TWST) reported reportable segment — cost of revenues of $47.4M in Q1 2026.
- How has Twist Bioscience Corporation's reportable segment — cost of revenues changed year-over-year?
- Twist Bioscience Corporation's reportable segment — cost of revenues increased by 17.4% year-over-year, from $40.37M to $47.4M.
- What does reportable segment — cost of revenues mean?
- Includes the direct costs attributable to the production of goods or the delivery of services provided by the reportable segment. Monitoring this metric helps assess the direct manufacturing efficiency and the impact of input costs on the segment's gross margin.
Ask your AI about Twist Bioscience Corporation's reportable segment — cost of revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude